• Your partner in difficult decisions

    Enabling solutions to meet patients needs

Framing the future of diagnostics

Roche is committed to finding innovative solutions for serious, currently unsolved medical challenges that will make a genuine difference to the lives of patients worldwide.

Read Article

Introducing the cobas m 511*

Using Bloodhound® technology, the cobas m 511 combines a digital morphology analyzer, cell counter and classifier into one streamlined instrument preparing, staining and analyzing microscopy blood smears.
*in development  Read More


Central nervous system diseases

Drugs designed to act on the brain often come to grief at the blood-brain barrier. The effective purpose of the barrier, found in all vertebrates, is to protect the brain from harmful  Read Article


New ways forward in virology

Viral disease represents an insidious and serious health risk. Viruses are often not detected early enough. This allows them to spread uncontrollably. Since viruses can quickly mutate Read Article


Targeted correction of metabolic disorders

Metabolic disorders can produce the most varied conditions, such as diabetes, arteriosclerosis or hypertension. In their effort to develop drugs against such widespread diseases Read Article


Research & Development at our German sites

Roche in Penzberg is situated on the foothills of the Alps near Munich, Germany. The campus is one of the largest Biotechnology-Centers in Europe, employing more than 5000 highly Read Article


Intervening in inflammatory disease mechanisms

Roche is conducting intensive research into the causes and natural history of inflammatory diseases. The results of this research Read Article